Gene editing through microfluidic delivery
AssigneesMassachusetts Institute of Technology, President and Fellows of Harvard College
InventorsArmon R. SHAREI, Marc LAJOIE, Klavs F. JENSEN, Robert S. LANGER
Life of this patent
Estimating the term…
Loading patent…
AssigneesMassachusetts Institute of Technology, President and Fellows of Harvard College
InventorsArmon R. SHAREI, Marc LAJOIE, Klavs F. JENSEN, Robert S. LANGER
Estimating the term…
Gene editing can be performed by introducing gene-editing components into a cell by mechanical cell disruption. Related apparatus, systems, techniques, and articles are also described. The methods and systems of the invention solve the problem of intracellular delivery of gene editing components and gene editing complexes to target cells. The results described herein indicate that delivery of gene editing components, e.g., protein, ribonucleic acid (RNA), and deoxyribonucleic acid (DNA), by mechanical disruption of cell membranes leads to successful gene editing. Because intracellular delivery of gene editing materials is a current challenge, the methods provide a robust mechanism to engineer target cells without the use of potentially harmful viral vectors or electric fields.
A method for delivering a protein and a nucleic acid into a cell, the method comprising:
A device for delivering a protein-nucleic acid complex to a cell, comprising at least one microfluidic channel, wherein said channel comprises a constriction length of about 30 μm and a constriction width of about 4 μm.
Dependencies are inferred from the claim text.